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Introduction: The present study was aimed to evaluate and compare adhesion, proliferation, and differentiation of stem cells originated from dental 
pulp, Buccal fat pad tissue, umbilical cord blood and bone marrow on the β- TCP scaffold. Materials and Methods: Human mesenchymal stem 
cells originated from dental pulp, Buccal fat pad tissue, umbilical cord blood and bone marrow were assessed in this study. The characteristics of 
mesenchymal stem cells evaluated by flow-cytometry. Biological properties such as cell number, alkaline phosphatase (ALP) activity, alizarin red 
and MTT assay evaluated during cell culture. The morphology of cells culture was also examined using a scanning electron microscope (SEM). The 
MTT assay results represented that the proliferation was time-dependent and the rate of proliferation and viability of any four mesenchymal stem 
cells were the same. Results: The SEM of hBFPSCs, hBMSCs, hDPSCs, hUCSCs at 5 days indicated that hBFPSCs have higher attachment. ALP 
enzyme activities revealed the highest at day 21 when the cells were cultured in differentiation media. The alizarin red staining results indicated a 
clear mineralization of hBMSCs is dramatically higher from three mesenchymal stem cells. Our findings showed that the origins of MSCs impel 
their proliferative and osteogenic sufficiency and thus influence their application as a cell sources for bone tissue engineering. Conclusion: Despite 
BMSCs are the best nominee for cell based bone regeneration according to the existing evidences, in clinical and in vivo conditions there are many 
circumstances may be encountered bone healing. 
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somatic stem cells (UCSCs) ; β- TCP 
 
Introduction 
Mesenchymal stem cells (MSCs) have been investigated as 
promising candidates for use in new cell-based therapy 
strategies. Cell-based therapies for bone regeneration commonly 
utilized mesenchymal stem cells (MSCs) derived from bone 
marrow (1-6). MSCs also can be isolated from a wide diversity 
of tissues such as; synovial membrane, skeletal muscle, adipose 
tissue, peripheral blood, periosteum, umbilical cord blood and 
dental tissues (7-10). There are increasing studies to investigate 
alternative source of mesenchymal stem cells be replaced to 
overcome the limitations of bone marrow-derived mesenchymal 
stem cells (BMSCs) (11-14). 
Buccal fat pad tissue is one of the richest sources of MSCs. 
Being Easy to harvest, obtaining the high number of the primary 
cells, having fewer risks and pain for removal of the larger 
volume of tissue and finally having high proliferative capacity 
have led buccal fat pad stem cells (BFPSCs) become an 
appropriate substitution MSCs (12, 15, 16). 
Recently, the unrestricted somatic stem cells (UCSCs) are 
separated from human umbilical cord blood. These cells have the 
potential to be distinguished into three embryonic layers and also 
they remain undifferentiated without deformation after long- term 
proliferation in vivo. In comparison with BMSCs, the isolation of 
these non-invasive cells is done much easier. Also UCSCs have 
better growth kinetics and a long lifetime i.e., up to more than 20 
passages. In addition, in term of ethical issues and immune system 
reactions, these cells are less problematic than embryonic cells (17).  
Dental pulp stem cells (DPSCs) are commonly obtained 
from wisdom teeth, deciduous teeth and apical papilla. Their 
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ability in regeneration of bones has been showed in various 
studies. It has been shown that DPSCs have more willing to be 
distinguished to transgenic/odontogenic categories (12, 17, 18).  
Studies showed that the proliferation and differentiation 
capacities of MSCs are influenced by several factors including 
tissue origins, age of donor, and cultivating factors (19). There is 
controversies in MSC-related literature regarding optimal 
source of MSC with high proliferation and differentiation 
potentials. Hence, the present study aimed to evaluate and 
compare the adhesion, proliferate, and differentiation of stem 
cells derived from dental pulp, buccal fat pad tissue, umbilical 
cord blood and bone marrow cultured on the β-tricalcium 
phosphate (β-TCP). 
Materials and Methods 
Stem cell culture 
hDPSCs were derived from pulp tissues obtained from wisdom  
teeth from healthy individuals in Department of oral and 
maxillofacial surgery at Shahid Beheshti University of Medical 
Sciences. After washing in sterile phosphate-buffered saline 
(PBS) (Sigma-Aldrich, Nst. Louis, Mo, United States), dental 
pulp were individually isolated from the pulp chamber of 
extracted teeth with sterile instruments (20).  
hBFPSCs were isolated from buccal fat pat tissues of a 
healthy individual who electively subjected to an aesthetic 
midface improvement (21). The pulp and adipose tissues were 
digested in a solution of 1% collagenase type I (Sigma-Aldrich, 
St. Louis, Mo, United States) for 1 hour at 37°C in incubator 
shaker. Then cells were re-suspend in growth medium 
containing Dulbecco's Modified Eagle Medium (DMEM) (Life 
Technologies, Carlsbad, CA, United States), 20% fetal bovine 
serum (FBS) (Life Technologies, Carlsbad, CA, United States), 
1% Penicillin-Streptomycin 10,000 u/ml (Life Technologies, 
Carlsbad, CA, United States). Cell suspension was transferred to 
a T-25 flask and incubated at 37°C and 5% CO2. Cells were 
cultured after 80-90% confluency. Medium were changed every 
3 days. Cells were trypsinised using 0.25% trypsin-EDTA (Life 
Technologies. Carlsbad, CA, United States) (22). 
hBMSCs and hUCSCs were obtained from stem cell bank of 
Bonyakhte institute, Tehran, Iran.  
Characterization of stem cells 
In order to check the percentage of MSCs (hBFPSCs, hBMSCs, 
hUCSCs, hDPSCs) phenotype, flow cytometry analysis for the 
expression of CD44, CD90, CD73, CD 105, CD45, and CD 34 
were performed.  
Cell seeding  
β -TCP granules (Lasak, Praha, Czech Republic) with pore size 
of 100-200 µm (macro pores) and 1-5 µm (micro pores) were 
used as 3D scaffold. 0.27 grams of β -TCP granules were placed 
in 24-well plates. Mesenchymal stem cells were cultured in 
medium (high glucose DMEM, 10% FBS, 1% Penicillin 
streptomycin) (23). Cells were harvested after 80-90 % 
confluence. 5 × 104 cells were suspended in 10 ml medium were 
seeded onto scaffolds. 1 hour, cells were incubated for cell 
attachment on the surface scaffolds; afterwards additional 
culture medium was added on scaffolds for overnight. Cell-
scaffold were cultured in standard growth or osteogenic 
(StemPro® Osteogenesis Differentiation Kit, Thermo Fisher 
scientific, Waltham, Massachusetts, United States) medium. 
Experiments were performed in triplicate. 
Cell adhesion and morphology evaluation  
The surface morphology of β-TCP scaffolds was examined using 
SEM, the cells on the scaffolds were fixed by 2.5% glutaraldehyde 
for 2 hours at room temperature. Dehydration cell-scaffold was 
done in a series of increasing concentrations of ethanol in 
distilled water 30%, 70%, 80%, 90%, and 100% for 10 min per 
each concentration. The samples were air- dried for 24 h. Finally, 
the scaffolds were sputter-coated with gold before SEM imaging 
(Hitachi, Tokyo, Japan). 
Cell viability evaluation  
To assess the proliferation of stem cells, 3-(4,5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (Sigma, St. 
Louis, Missouri, United States) and DNA counting assay were 
performed. After 24 and 72 h, 20 µL of MTT was added and 
incubated for another 4 h at 37°C. The supernatant was removed 
and dimethyl sulfoxide (DMSO) (Roche, Basel, Switzerland) was 
added to each well for 10 min to dissolve any formazan crystals 
formation. The absorbance was read by absorption at 570 nm 
using ELIZA reader (BioTek, Winooski, VT, USA) in 96 well-
plate. Cell-scaffolds were 3D cultured in stem cell growth 
medium with 7 and 14 days. 
Proliferation of four mesenchymal stem cells (hBFPSCs, 
hBMSCs, hDPSCs, hUCSCs) were evaluated using DNA 
counting assay. 
Briefly, cell-scaffolds were lyzed in Trizol solution (Life 
Technologies, Carlsbad, CA, United States) and incubated at 
room temperature for 10 min. This was followed by phase 
separation step by adding chloroform, then cold centrifugation 
to collect the DNA as a pellet in the bottom of the micro-
centrifuge tubes. DNA then was washed and dissolved in 8 
millimolar concentration NaoH solution. The DNA 
concentration was measured at the wavelength of 260 nm by 
Nanodrop (Thermo Scientific, Waltham, MA, United States). 
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Figure 1. Evaluation of four mesenchymal stem cells (hBFPSCs, hBMSCs, hDPSCs, hUCSCs) attachment on β-TCP granules by Scanning 
electron microscopy (SEM). Four mesenchymal stem cells (hBFPSCs, hBMSCs, hDPSCs, hUCSCs) were grown in standard stem cell medium. A-
D (hBFPSCs); E-H (hBMSCs); I-H (hDPSCs); M-P (hUCSCs) on β-TCP granules. Note SEM figures showed that adhesion and proliferation of 
hBFPSCs on β-TCP granules is obviously higher between other three mesenchymal stem cells (hBMSCs, hDPSCs, hUCSCs) 
 
Osteogenic differentiation assay 
Cells were seeded at a density of 5 × 104 on β-TCP scaffolds in 
growth medium overnight. Then, the culture medium was 
changed to osteogenic medium. Osteogenic medium was 
changed every 3 days. Cells were harvested at 7 and 21 days. 
Osteogenic differentiation was evaluated by alkaline 
phosphatase (ALP) activity assay. The cells were lysed by RIPA 
buffer (Thermo scientific, Waltham, Massachusetts, United 
States) on ice for adjustment 30 minutes. The resulting mixture 
of lysis buffer, and then was centrifuged at 15000 rpm for 30 min 
at 4 °C. The cell lysate mixed with p-nitrophenol phosphate 
substrate solution (Sigma Aldrich, St. Louis, Missouri, United 
States). After incubation at 37 °C for 30 min, the above mixture 
was added to 0.5(N) NaOH to stop the reaction. The absorbance 
at 405 nm was measured using ELIZA reader (BioTek, 
Winooski, VT, United States). 
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Figure 2. Evaluation of proliferation of four mesenchymal stem cells 
(hBFPSCs, hBMSCs, hDPSCs, hUCSCs) in standard stem cell medium 
on β-TCP granules by MTT assay after 24 and 72 hours. Note that the 
results of MTT assay clearly revealed the percentages of cell viability at 
72 hours in comparison to 24 hours are significantly increased 
 
Mineralization assessment  
The formation of mineralized matrix nodules was determined by 
alizarin red staining (Sigma, St. Louis, Missouri, United States). 
Trypsinizing from granules, the cells were fixed in 70% ethanol for 
1h at room temperature. The fixed cells were washed with PBS  
Statistical analysis 
In this study, all the experiments were accomplished in triplicate 
and all data were analyzed by SPSS version 20.0.1 (IBM Corp., 
Armonk, NY, USA). Findings were compared between groups for 
conditioned three mesenchymal stem cells, time points and 
absorbance studies singly with analysis of variance ANOVA by 
pair-wise comparison. For all comparisons, the degree of 
importance was P≤ 0.05 and Tukey's test were used as the post hoc. 
Results 
Characterization of hBFPSCs, hBMSCs, hDPSCs,hUCSCs  
Flow cytometric analysis of hBFPSCs, hBMSCs, hDPSCs, hUCSCs 
mesenchymal stem cell indicated a consistent immunophenotype 
in which was positive for mesenchymal markers (CD73 [SH3] and 
CD105 [SH2]) and cell adhesion molecules (CD 44 and CD 90). 
Hematopoietic markers (CD34 and CD45) were expressed at very 
low percentages of the cells (Table 1). 
Cell adhesion and morphology 
All stem cells demonstrated a similar spindle shaped morphology 
in 2D monolayer culture. Figure 1 represents SEM of hBFPSCs, 
hBMSCs, hDPSCs, hUCSCs in 3D scaffold culture at 5 days. 
hBFPSCs showed better adhesion to the scaffold among the study 
groups. 
 
Figure 3. Evaluation of cell viability of four mesenchymal stem cells 
(hBFPSCs, hBMSCs, hDPSCs, hUCSCs) in growth medium on β-TCP 
granules by cell counting assay after 7 and 14 days. Note that charts 
represent the number of cell viability are clearly increased after 14 
days. Means and standard deviations of each group calculated and 
statistical significance was assessed by ANOVA and Tukey's post hoc 
test (*P<0.05 in comparison to all other groups at the same time point) 
 
Cell proliferation and viability 
Figure 2 shows the proliferation and viability of hBFPSCs, 
hBMSCs, hDPSCs, hUCSCs on β-TCP granules in 2D monolayer 
cultures quantified cell number using MTT assay at different time 
points 24 and 72 hours. Although hBFPSCs demonstrated the 
highest proliferation and hUCSCs showed the lowest proliferation 
within the experimental groups at 24 hours, the differences were 
not statistically significant. All stem cells indicated nearly the same 
proliferation rate after 72 hours. 
Moreover, the proliferation and viability of four mesenchymal 
stem cells (BFPSCs, BMSCs, hDPSCs, hUCSCs) on β-TCP granules 
in 3D scaffold culture were quantified using DNA counting assay at 7 
and 14 days (Figure 3). The results demonstrated no significant 
differences between experimental groups after 7 days. The amount of 
DNA in hDPSCs was higher significantly at 14 days (P value<0.05). 
Osteogenic differentiation 
ALP activity increased after 7 days and the levels were nearly the 
same in all groups (P>0.05). There was a statistically significant 
difference between ALP activities in hBFPSCs, hDPSCs, hUCSCs 
during differentiation into osteoblast cells, as compared to the 
hBMSCs on the 21st day (P value<0.05) (Figure 4). 
Mineralization  
High positive in alizarin red staining results were indicated 
throughout the all experimental groups 3D cultured on β-TCP 
granules at 7 and 21 days (Figure 5). Quantitative analysis of the 
alizarin red was clearly illustrated mineralization of hBMSCs is 
statistically higher than three other stem cells (P<0.05). 
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Figure 4. Evaluation of ALP of four mesenchymal stem cells 
(hBFPSCs, hBMSCs, hDPSCs, hUCSCs) in osteogenic medium on β-
TCP granules by ALP activity after 7 and 21 days. Note that 
representative graph of ALP activity of four mesenchymal stem cells 
(hBFPSCs, hBMSCs, hDPSCs, hUCSCs) illustrate a clear increase in 
ALP activity compared to 7 days. Human bone marrow stem cells 
(hBMSCs) significantly showed the increase in ALP activity of three 
other mesenchymal stem cells (hBFPSCs, hDPSCs, hUCSCs). Means 
and standard deviations of each group calculated and statistical 
significance was assessed by ANOVA and Tukey's post hoc test 
(*P<0.05 in comparison to all other groups at the same time point) 
Discussion 
Plenty of studies conducted to compare the proliferation and 
differentiation of stem cells from different sources, but the 
question pertaining to which source can provide the ideal stem 
cells is still controversial. Despite of all cell therapies advantages, 
critical-sized defects demand scaffold placement inevitably in 
addition to stem cells to further support tissue regeneration. 
Therefore assessment of cell behaviors in contact with scaffolds 
is of greater importance. Rodrigues et al., demonstrated that 
amniotic fluid- derived stem cells (AFSCs) showed higher 
calcium content in 2D culturing, while BMSCs outperformed 
AFSCs when seeded on scaffolds at the same time points. 
Compromising the AFSCs viability prior to mineral deposition 
in 2D culture can be the source of these diverse responses (25). 
Moreover scaffold compositions such as hydroxyapatite can act 
as nucleation sites and accelerate the new mineral structure 
formation (26). The fact can alter cell reactions with lower 
differentiation potential. Consequently, presence of scaffolds 
can elicit distinct cell responses such as proliferation and 
differentiation. In the present study, we compared in vitro 
osteogenic capacity of stem cells derived from dental pulp, 
buccal fat pad, umbilical cord blood and bone marrow seeded 
 
Figure 5. Evaluation of osteoblast differentiation of four mesenchymal 
stem cells (hBFPSCs, hBMSCs, hDPSCs, hUCSCs) in osteogenic 
medium on β-TCP granules by alizarin red staining after 7 and 21 days. 
Note that Alizarin Red staining quantification assay was clearly indicate 
the increase of number of mineralized nodules on day 21 in comparison 
7 days. In addition, hBMSCs obviously illustrate higher mineralization 
between three other mesenchymal stem cells (hBFPSCs, hDPSCs, 
hUCSCs) after 21 days. Means and standard deviations of each group 
calculated and statistical significance was assessed by ANOVA and 
Tukey's post hoc test (*P<0.05 in comparison to all other groups at the 
same time point) once. Alizarin red staining at pH 4.2 was added to each 
well for 30 min at room temperature. Acetic acid was included and 
scraped all of mixtures. Transfer mixtures to micro tubes. Incubate 
micro tubes at 85Ċ for 10 minutes. Quantitative analysis of alizarin red S 
staining was measured the absorbance at 405 nm using ELIZA reader 
(BioTek, Winooski, VT, United States). 
 
on the β-TCP, regarded as an excellent osteoconductive scaffold 
materials for bone tissue engineering. All stem cells showed 
original features of MSCs assessed by flow cytometric analysis. 
Proliferation: Over the last decade, BMSCs, ASCs, UCSCs 
and DPSCs have become easily attainable origins of stem cell 
derivation for bone regeneration application. However, BMSCs 
are still the most repeatedly studied cells. Studies by De Ugarte 
et al., and Shafiee et al., investigated proliferation capability of 
human BMSCs in comparison with human adipose-derived 
stem cells (ASCs). They concluded that ASCs exhibited higher 
cell numbers, albeit with no significant differences (27, 28). Our 
results also indicate similar proliferation rate of these two cells 
observed by MTT assay. The higher proliferation capability of 
ASCs have been approved to be related to higher expression of 
cell division cycle associated 8 (CDCA8), and cyclin B2 
(CCNB2) gens in ASCs than in BMSCs (29). In contrast, BrdU 
assay of rat stem cells showed greater viability of adipose-reside 
cells than BMSCs (30). Furthermore, Elkhenany recently 
revealed the diversity of low passaged stem cells features versus 
high passaged ones. They evaluated the proliferation potential of 
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goat adipose and bone marrow cells, and showed higher viability 
of low passaged BMSCs than the ASCs counterparts. However, 
the cells in passage 12-14 were approximately similar (29). 
Donor species-associated variability may be the origin of these 
inconsistent results as Izadpanah showed. He declared that 
rhesus bone marrow stem cells and human adipose tissue 
exhibited similar growth kinetics and shorter doubling time 
than rhesus ASCs and human BMSCs (31). Regarding 
proliferation of dental-derived stem cells from permanent or 
deciduous teeth and their collation to BMSCs, almost all papers 
reported the superior colony-forming ability and cell numbers 
of DPSCs than BMSCs (32-36). We found the same results by 
DNA counting. These outcomes support the hypothesis which 
indicated that dental pulp-derived stem cells possess more 
primitive MSC-like cells (35).  Nevertheless, Study of Davis 
represented the lower growth curve of DPSCs compared to 
BMSCs and ASCs (37). Although, majority of DPSCs were 
isolated from intact teeth, Rajendran successfully attained stem 
cells from extracted primary teeth with high caries since the 
inflammation increased the homing of stem cells and growth 
factors and promote cell proliferation and differentiation (33). 
Stem cells with fetal origin such as ones from umbilical cord, 
Wharton jelly, fetal membrane and placenta undisputedly 
illustrated more cell numbers than ASCs or BMSCs due to their 
primitive source, similar to our results (38-41). In addition, they 
stopped proliferation in upper passage numbers with slower 
senescence rate. Wharton jelly’s stem cells seeded on hyaluronan 
demonstrated higher viability compared to BMSCs and ASCs as 
well (42). All these differences appear to be dependent on the 
source of cell derivation. However, analogous tissues with 
different sites also can cause biological differences as ASCs from 
subcutaneous adipose tissue proliferated faster than Bichat’s fat 
pad and owned considerably shorter population doubling time 
(43). Comparisons of other stem cell sources are depicted in 
table 2 and table 3 revealed combination of various MSCs and 
scaffolds for bone regeneration.  
Differentiation: Beside to proliferation capacity, great 
differentiation potential of derived-stem cells plays a pivotal role 
in osteogenesis. We exploited ALP activity test and Alizarin red 
staining for the aim. Consonant results of mentioned analyses 
showed the superior differentiation of BMSCs compared to 
ASCs, DPSCs and UCSCs. Similarly, study of Shafiee, Kato and 
Wong reported higher amount of mineralization by BMSCs 
than ASCs in osteogenic medium, as a differentiation indicator 
(43, 44). Ongaro and his coworkers represented identical 
outcomes in presence of BMP-2 and exposure of pulsed 
electromagnetic field (45). One probable explanation of the fact 
could be stated by lower expression of BMP-2 and BMP-4 in 
ASCs (46). Although many studies corroborated the better 
differentiation capability of BMSCs, some approved the similar 
osteogenic activity of BMSCs and ASCs (47). Expansion of cells 
by serial passaging can alter the biological properties. Low 
passaged-BMSCs, which exhibited greater osteogenesis 
potential comparing to ASCs, lost their superior differentiation 
capacity when passaged to 12-14 and showed less alizarin red 
intensity than high passaged-ASCs (30). Our experiments were 
conducted by cells with 3-5 passage numbers for all sources to 
ensure the biological susceptibility of cells during culturing time. 
Regarding comparison of BMSCs and DPSCs, some researchers 
strongly suggested that dental derived-cells are more 
appropriate for bone engineering due to their higher osteoblastic 
differentiation (35-37), while others confirmed that both 
possessed similar osteogenic capacity (32-34). Intriguingly, we 
found that the cells expressed diverse manners when seeded on 
TCP granules, and BMSCs outperformed DPSCs in terms of 
ALP activity and calcium staining. Ponnaiyan observed that 
DPSCs expressed lower level of CD105, a cell migration-related 
marker (36). This factor may be the answer of why DPSCs did 
not differentiate as well as BMSCs on our scaffolds. Following 3 
weeks of in vitro culturing, we demonstrated that UCSCs has less 
osteogenic potential than BMSCs, while they showed similar 
behavior to ASCs, in this regard. Hsieh and Choudhery studied 
the osteogenic differentiation of umbilical cord-derived stem 
cells and remarked the lower capacity of these fetal originated 
stem cells compared to BMSCs and ASCs, respectively (38, 39). 
Schneider et al., seeded BMSCs and Wharton jelly derived-
MSCs on collagen scaffolds. They observed that BMSCs 
expressed higher ALP and OPN markers on cultures with or 
without scaffolds (48). In contrast, culturing the UCSCs and 
BMSCs on calcium phosphate cement mixed with chitosan and 
polyglactin fiber represented larger percentage of mineral area 
on UCSCs-seeded scaffolds (49). Also, addition of osteoactivin 
to osteogenic medium enhanced the differentiation potential of 
MSCs isolated from fetal membrane and showed greater amount 
of stained deposition than BMSCs (41). Medium 
supplementation have been carried out by variety of substances 
such as inorganic phosphate, Dentine matrix components, 
BMP-2, TNF-α, IL-1b and retinoic acid (37, 50, 51). Various 
incubation conditions could elicit specific features of each stem 
cell. For instance, Rui found that addition of BMP-2 to medium 
increased ALP activity and Alizarin red staining in tendon 
derived stem cells which did not observed for BMSCs (52). Our 
experiments were executed under standard osteogenic medium 
composed of dexamethasone, ascorbic acid and β-glycerol 
phosphate. Together with all confounding factors, the duration 
of culturing prior to differentiation assessment is of key 
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Table 1. Expression profiles of surface markers of MSCs by flow cytometry 
Cell type  CD73 CD105 CD44 CD90 CD34 CD45 
hBFPSCs  + + + + - - 
hBMSCs + + + + - - 
hDPSCs + + + + - - 
hUCSCs + + + + - - 
 
Table 2. Comparison of MSCs from various sources 
Author(s) 
 
Cell types Culture 
condition 
Flow cytometry Results 
Brocher J et al. 
,(2013) 
-BMSCs from iliac crest 
marrow aspirates 
-Human ASCs from surgical 



















-ASC, BMSC:-  
Differentiation: 
ALP activity(1, 7, 14, 21 d) (ng ALP/ng protein/ml/min): 
ASC: 4.30 ± 1.22 
BMSC: 4.37 ± 2.20  
RT-PCR: 
-ANGPT1: BMSC>ASC-VEGF: BMSC>ASC 
-IL-6: BMSC>ASC-BMP-4: BMSC>ASC 
-BMP-2: BMSC>ASC-ADIPOQ: BMSC<ASC 
-NAMPT: BMSC<ASC 
Elkhenany H et 
al.,(2016) 
-Goat/caprine BMSCs 
-ASCs from the inguinal area 




-2-3: low P 
-12-14:high P 
- Proliferation/viability: 
CFU assay (7 d) 
-4 cells grew in clusters. 
MTS assay (2, 7, 10 d)  
-BMSCs low and ASCs low numbers increased linearly and 
notably with time but this increase pattern did not occur in the 
cells high 
- BMSCs low> ASCs low in all time points. 
- BMSCs high ≅ ASCs high  
Differentiation: 
Alizarin red staining(7, 14, 21 d) 
-BMSCs low > ASCs high> BMSCs high> ASCs low except for day 7 
that groups showed similar mineralization. 
Western blot analysis(7, 14, 21 d) 
- p44/42 was significantly up-regulated in ASCs low and high 
- p38 and OPN were significantly up-regulated in BMSCs low on 
d21 after osteogenic differentiation  
- BMP-7 was significantly up-regulated in ASCs low and high, but 
BMSCs low and high expressed BMP-7 lower than ASCs. 
Immunofluorescence (DAPI staining): 
- ASCshigh showed adipocyte morphology when induced to 
osteogenic differentiation 
Ongaro A et 
al.,(2014) 
-Human BMSCs  
 
-ASCs from liposuction of 
























OM  BMP-2 and 
Flow cytometry: 
CD29, CD44, CD73, CD90, 
CD105: 
ASCs:+ 
CD14, CD34, CD45: 
ASCs:-  
Differentiation assay:  
ALP activity(3, 7, 11, 14, 21, 28 d) 
-BMSCs: 
d 3: PEMFs+ BMP-2≅ PEMFs+OM≅ BMP-2+OM≅OM 
d 7,11: PEMFs+ BMP-2> PEMFs+OM> BMP-2+OM>OM 
d 14: PEMFs+ BMP-2> PEMFs+OM ≅BMP-2+OM>OM 
d 21,28: PEMFs+ BMP-2> BMP-2+OM> OM> PEMFs+OM 
-ASCs: 
d 3: PEMFs+ BMP-2> BMP-2+OM≅ OM> PEMFs+OM 
d 7: PEMFs+ BMP-2≅ BMP-2+OM> PEMFs+OM > OM 
d 11: PEMFs+ BMP-2> PEMFs+OM> BMP-2+OM>OM 
d 14: PEMFs+ BMP-2> PEMFs+OM > OM >BMP-2+OM 
d 21: BMP-2+OM> PEMFs+ BMP-2 ≅ OM > PEMFs+OM 
d 28: PEMFs+OM > PEMFs+ BMP-2> OM ≅ BMP-2+OM 
-In all time points: ASCs<BMSCs 
Alizarin red staining(14 d) 
-BMSCs: PEMFs+ BMP-2> PEMFs+OM> BMP-2+OM>OM 
-ASCs: PEMFs+ BMP-2≅PEMFs+OM> BMP-2+OM>OM 
ELISA of OCN level(ng /µg DNA) (3, 7, 11, 14, 21, 28 d): 
-BMSCs: 
   d 3,7,11,14:PEMFs+ BMP-2≅PEMFs+OM≅BMP-2+OM 
≅OM 
   d 21, 28: PEMFs+ BMP-2> PEMFs+OM> BMP-2+OM >OM 
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in the presence or 




   d 3,7,11,14:PEMFs+BMP-2≅PEMFs+OM≅ BMP-2+OM 
≅OM 
   d 21, 28: PEMFs+ BMP-2≅ PEMFs+OM> BMP-2+OM ≅OM 
-In all time points: ASCs<BMSCs 
Shafiee A et al., 
(2011) 
-BMSCs  


















Cell count and Growth curve: 
- ASC> BMSC 
Morphology/attachment: 
-Both cells showed fibroblast-like and spindle-shaped 
morphology  
Differentiation: 
Alizarin red staining(3 w): 
-Both cells formed mineralized matrix.  
ALP activity(0, 7, 14, 21 d): 
-BMSC> ASC 
Calcium content(0, 7, 14, 21 d): 
-BMSC> ASC 
RT-PCR(0, 7, 14 d): 
ALP: ON 
d 0: BMSC≅ ASC d 0: ASC> BMSC 
d 7,14: BMSC> ASC d 7,14: BMSC> ASC 
Col I  OCN 
d 0: ASC> BMSC d 0,7: BMSC> ASC 
d 7,14: BMSC≅ ASC d 14: ASC> BMSC 
Runx2 BMP-2 
d 0,7: BMSC> ASC d 0: ASC> BMSC 
d 14: BMSC≅ ASC d 7: BMSC≅ ASC 
 d 14: BMSC> ASC 
De Ugarte DA et al., 
(2003) 
-BMSCs of patients 
undergoing hip surgery 
-ASCs from patients 






Population doubling time(h)(3-9 d): 
-BMSCs: 86  23 
-ASCs: 78  26  
Cell count: 
-The mean number of cells isolated per gram of bone marrow 
was considerably greater than of adipose tissue 
Senescence-associated β-Gal staining (%)(2 w) 
-BMSCs ≅ 4 
-ASCs ≅ 3 
Differentiation(3 w): 
ALP activity(nmol p-nitrophenol produced/min/Ìg protein): 
-BMSCs: 0.08  0.07 
-ASCs: 0.10  0.12 
Calcium content(Ca/µg protein): 
-BMSCs: 42  55 
-ASCs: 33  38 
Stöckl S et al.,(2013) -BMSCs of rats 
-ASCs obtained from 






-BMSC, ASC (P 1,2) > 96 
 
CD45: 
-BMSC (P 1)≅4 
              (P 2):0.52 
-ASC     (P 1):1.48 
 (P 2):2.24 
CD11b: 
-BMSC  (P 1):11.2 
 (P 2):1.29 
-ASC     (P 1):2.06 




-VEGFα: ASC> BMSC 
-ALP, Mmp13, Integrinα11, OCN: ASC< BMSC 
-Col1a1, SOX9, Runx2: ASC ≅ BMSC 
P 2: 
-SOX9, Integrinα11, OCN, Runx2, VEGFα, Col1a1: ASC> 
BMSC 
-MMP13: ASC< BMSC 
-ALP: ASC≅ BMSC 
Western blot analysis: 
-SOX9 increased strongly in ASC from P 1 to 2 while SOX9 
expression reduced in BMSCs. 
Alizarin Red staining:  
-Mineralization observed in both BMSCs and ASC. 
Wong H et al., 
(2015) 
-FDSCs from the fascia of the 
left gluteus maximus of the 
rats 
-ASCs from the inguinal fat 
pad of the rats 




and 10% FBS 
Differentiation 
assessment: OM 
P: 2   
Flow cytometry: 
CD11b, CD31, CD34, 
CD45: 
-BMSCs, ASCs, FDSCs:- 
CD44, CD71, CD90: 






-0.5%FBS: FDSCs > ASCs> BMSCs 
-10%FBS: ASCs ≅ FDSCs> BMSCs 
CFU assay(14 d): 
-FDSCs formed more colonies with bigger size than BMSCs, 
ASCs. 
MTT assay: 
-0.5%FBS: FDSCs> ASCs> BMSCs 
-10%FBS: ASCs> FDSCs> BMSCs 
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Morphology/attachment: 
Inverted light microscope(7,14 d) 
-Both cells represented similar fibroblastlike cell morphology 
in similar growth conditions. 
Differentiation: 
RT-PCR, cell marker analysis(7, 14 d) 
Oct4 : ASCs> FDSCs> BMSCs 
Sox2: ASCs> FDSCs> BMSCs 
Klf4: BMSCs> FDSCs> ASCs 
RT-PCR, gene expression analysis(7 d) 
-Runx2, ALP, OPN, ON in both ASCs and FDSCs were lower 
than in the BMSCs. 
Alizarin red staining(28 d) 
-BMSCs showed the highest amount of mineralization. 
Jin Jin H et 
al.,(2013) 
-Human BMSCs were 
isolated by aspiration  
-ASCs obtained from elective 
liposuction procedures  
-UCSCs from umbilical veins 






CD 11b, CD 14, CD 19a, 
CD 34, CD 45, CD 79a, 
HLA DR: 
-BMSC, ASC, UCSC:- 
CD 29, CD 44, CD 7, CD 
90, CD 105, CD 166, HLA 
ABC: 
-BMSC, ASC, UCSC:+  
Proliferation/viability: 
CFU assay (P 3) 
-UCSC > BMSC or ASC 
Population doubling time(P 5-6) and (P 11-12) 
-In both Ps UCSC< BMSC, ASC  
Senescence-associated β-Gal staining (Gal Staining) 
-Expression of senescence-associated proteins in each MSC 
(P5> P8 >P11) 
- UCSC < BMSC, ASC 
Differentiation: 
Western blot analysis(P 12) 
-P53, P16, P21 proteins :  
-P5,8,11: UCSC< ATSC, BMSC 
-P12: BMSC> ASC> UCSC 
-P11>P8>P5 
Davis OG et al. 
(2014) 
-ASCs from inguinal fat pads 
of rats 
 
-BMSCs from femora of rats 
 





DMCs were added 






Flow cytometry(P 2) 
CD90, CD29, CD29/ 
CD90-positive:  
-BMSCs ≅ DPSCs 
 
RT-PCR(P 0-4): 
CD29, CD44, CD73, CD90, 
CD105(P 1-4) 




-BMSCs, DPSCs – 
 
Proliferation/viability: 
Cell count and growth curve (0, 3, 6, 9,12, 15, 18, 21 d) 
BMSCs ≅ ASCs> DPSCs 
Differentiation: 
Alizarin red staining(21 d): 
-DPSCs> BMSCs> ASCs 
-Addition of DMCs to OM showed significant increase in 
calcium deposition while it did not affect calcium content when 
added to culture medium 
SEM(Examination of mineralization)(21 d) 
-ASCs: smaller nodules 
-BMSCs: larger nodules 
-DPSCs: layer of mineralized matrix without distinct nodular 
formation 
Burning/ashing exams(Quantification of total inorganic 
content)(21 d) 
-DPSCs>BMSCs≅ASCs 
Kato T et al.,(2011) -BMSCs from femoral bone 
marrow of Fischer rats 
-ASCs from rat inguinal 
adipose tissue 
-PDLSCs from rat maxillary 





















Flow cytometry(1 w): 
CD29, CD90: 
-BMSCs, ASCs, PDLSCs:+ 
 
CD31, CD44, CD45 and 
CD172: 
-BMSCs, ASCs, PDLSCs:-  
Proliferation/viability: 
BrdU assay(1 w): 
-ASCs > BMSCs >PDLSCs 
Differentiation(2 w): 
ALP activity: 
-Non-diffrentiation condition: PDLSCs> BMSCs> ASCs ≅0 
-Differentiation condition: BMSCs>PDLSCs> ASCs ≅0 





BMSCs, PDLSCs:+ and BMSCs>PDLSCs 
ASCs:- 
RT–PCR analysis, 
Calcein uptake assay(fluorescence intensity) 
-Non-diffrentiation condition: PDLSCs> BMSCs >ASCs  
-Differentiation condition: BMSCs>PDLSCs> ASCs ≅0 
OCN content(ng/ml): 
-Non-diffrentiation condition: PDLSCs> BMSCs ≅ ASCs ≅0 
-Differentiation condition: BMSCs>PDLSCs> ASCs ≅0 
RT-PCR (OCN expression) 
-Non-diffrentiation condition: PDLSCs> BMSCs, ASCs ≅0 
-Differentiation condition: BMSCs>PDLSCs> ASCs  
Rajendran, R et 
al.,(2013) 
-DPSCs from the pulp tissue 




CD44:                             CD90: 
Proliferation/viability: 
CFU Assay with various seeding cell densities of 50, 100, 500, 
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with high caries 
 
-BMSCs from the iliac crest  
OM 
 
-DPSC: 99.70                    -
DPSC: 94.84 
-BMSC: 95.42                   -
BMSC: 85.00 
CD 105:                             CD 
73: 
DPSC: 99.12                     -
DPSC: 99.52 
BMSC: 96.34                    -
BMSC: 98.24 
CD166:                              CD34: 
DPSC: 99.52                     -
DPSC: 0.08 
BMSC: 98.04                    -
BMSC: 0.34 
CD45:                                HLA-
DR: 
DPSC: 0.06                       -
DPSC: 0.10 
BMSC: 0.32                      -
BMSC:1.92 
1000 (P 1)(14 d)(number of colonies) 
-DPSCs -BMSCs 
50 cells seeded:1    50 cells seeded:4 
100 cells seeded:8    100 cells seeded:7 
500 cells seeded:33  500 cells seeded:28 
1000 cells seeded:65 1000 cells seeded:44 




Von Kossa Staining(4 w): 
-BMSCs and DPSCs showed similar rate of osteogenic 
differentiation. 
Alge D. et al.(2010) -DPSCs isolated from the rat 
incisors 
 
-BMSCs from the tibia and 




P number: 3-5 
Flow cytometry(%): 
CD29, CD59, CD90, 
CD106: 
-DPSCs, BMSCs  95 
CD45, CD11b: 
-DPSCs, BMSCs ≤ 5 
Proliferation/viability: 
Population doubling time(P 3): 
-DPSC: 39.6 ± 2.5 h 
-BMSC: 61.7 ± 4.1 h 
CFU assay (colonies per 1,000 cells plated) (14-21 d): 
-DPSC: 151.5 ± 52.3 
-BMSC: 63.8 ± 18.1 
Morphology/attachment: 
SEM(2, 5 d) 
-Both DPSC and BMSC exhibited a fibroblastic morphology. 
Differentiation: 
ALP activity: (nmole/ mg*min)(3 w) 
-DPSC: 121.3 ± 31.3 
-BMSC: 67.7 ± 5.4 
Alizarin red staining(3 w): 
-Both cells showed mineralized nodules formation. 
RT-PCR(1 w): 
OPN: BMSC> DPSC 
Runx2: BMSC<DPSC 
Ponnaiyan D et al., 
(2014) 
-Human BMSCs from the 
sternums of patients 
 












-BMSCs: 32.45 ± 1.7 
-DPSCs: 89.1 ± 1.4 
CD105: 
-BMSCs: 83.14 ± 1.94 




Cell count and Growth curve(P 3)(0, 3, 6, 9, 12 d): 
-DPSCs> BMSCs 
CFU assay(%)(14 d): 
-BMSCs: 19.00 ± 2.16 
-DPSCs: 26.67 ± 1.70 
Morphology/attachment(early P):  
phase contrast microscope and Wright-Giemsa staining: 
-Colonies and adhered fibroblast-like cells (spindle-shape and 
elongated morphology) of BMSCs and DPSCs observed. 
Differentiation(4 w): 
Alizarin red staining: 
-DPSCs exhibited more osteogenic potential. 
RT-PCR: 
ON: DPSCs> BMSCs 
ALP: DPSCs> BMSCs 



















-DPSCs,  BMSCs:+ 
 
CD45, CD34, CD14: 
-DPSCs,  BMSCs:- 
 
Proliferation/viability: 
DNA content counting by H-Thymidine labeling(15 d): 
-DPSCs > BMSCs 
Effect on T-cell proliferation(3 d): 
- DPSCs and  BMSCs prevented T-cells proliferation 753% 
and 
914% inhibition, respectively. 
Morphology/attachment: 
Light microscope(3 w): 
-Both cells represented spindle-shape and well-spread attached 
morphology 
Differentiation: 
ALP activity and Von Kossa staining(3-4 w): 
-Both cells showed similar osteogenic differentiation. 
Yamaza T et 
al.,(2010) 




Flow cytometry(P 3)(%): 
STRO-1                          CD146  
Proliferation/viability: 
CFU (10 d), BrdU (18 h) and RT-PCR for telomerase activity 
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-SHED: 12.06                -
SHED:48.39 
-BMSCs: 8.36                -
BMSCs:31.19 
 
SSEA-4                           CD73 
-SHED: 85.40                -
SHED:91.93 
-BMSCs: 80.64              -
BMSCs:88.1 
CD105                            CD166 
-SHED: 6.77                  -
SHED:63.65 
-BMSCs:  13.2               -
BMSCs:74.93 
CD34                              CD45 
-SHED: 0                       -
SHED: 0 
-BMSCs: 0.2                  -
BMSCs:0.5 
assay: 
-SHED > BMSCs 
Differentiation: 
ALP activity(1 w): 
-SHED ≅ BMSCs with a slight priority of SHED  in OM and 
control medium 
Western blot analysis(1 w): 
-SHED was similar to BMSCs in expression of elevated levels of 
ALP, Runx2, DSP, and OCN markers. 
Alizarin red staining(mineralized area/total area)(4 w): 
-SHED ≅ BMSCs 
 
Hsieh JY et al., 
(2010) 












CD29, CD73, CD44: + 
CD14, CD34, CD45: - 
Proliferation/viability: 
Cell count(0-20 d): 
-WJSCs> BMSCs 
Population doubling time(0-20 d): 
-WJSCs> BMSCs 
Differentiation: 
ALP activity(0, 1, 2, 3, 4 w): 
-BMSCs> WJSCs 
Von Kossa staining(0, 1, 2, 3, 4 w): 
-Bone nodules were detectable in BMSCs after 3 weeks but did 
not observed in WJSCs even after 4 weeks. 
RT-PCR: 
Osteogenic-related genes: 
DMEM+10% FBS: Runx2, OPN: BMSCs> WJSCs 
OM: ALP, OPN, Runx2: BMSCs>WJSCs 
Growth related-genes: WJSCs> BMSCs 
Neurogenesis related-genes: WJSCs> BMSCs 
Immune response related-genes: BMSCs> WJSCs 
Choudhery MS et 
al.,(2013) 
-ASCs were obtained from 
liposuction procedure during 













Flow cytometry(%)(P 1): 
CD44                              CD73 
-ASCs: 99.5                    -
ASCs: 98.9 
-UCSCs: 99.1                 -
UCSCs: 99.2 
 
CD90                              CD105 
-ASCs: 98.3                    -
ASCs: 99.4 
-UCSCs: 99.4                 -
UCSCs: 96.5 
 
CD3                               CD14/34 
-ASCs: 2.7                     -ASCs: 
0.1 
-UCSCs: 1.3                  -
UCSCs: 0.1 
 
CD19                              CD45 
-ASCs: 2.5                     -ASCs: 
0.1 




CFU assay(14 d): 
-UCSCs: 69.0 ± 4.8 
-ASCs: 96.1 ±  3.1 
Population doubling time(d): 
-ASCs: 2.7  0.03 
-UCSCs: 2.0  0.04 
Number of cells at saturation density(initial seeding=25,000)(0-
20 d): 
-ASCs: 745,200   28,940 
-UCSCs: 836,513  21,063 
Morphology/attachment: 
-P 2: Similar homogeneous population of cells with identical 
fibroblastic morphology observed for both cell types. 
-P 10: UCSCs showed more changes in morphology and the 
proliferative potential of these cells reduced more rapidly than 
ASCs. 
Differentiation (3 w) 
Von Kossa staining(%positive area): 
-ASCs: 22.1  1.6 
-UCSCs: 13.5  3.2 
RT-PCR: 
ALP: ASCs ≅ UCSCs 
OCN: ASCs> UCSCs 
                        
Immunofluorescence (DAPI) staining(%ON positive cells): 
-ASCs: 60.0  7.6 
-UCSCs: 47.6  12.6 
Ogata Y et al.,(2015) -BMSCs obtained during 
total knee arthroplasty 
surgery 
 
-SySCs obtained during total 














CFU assay(2-7 w)( isolated THY-1+ and THY-1- cells from BM 
and Sy were assessed for proliferation) 
-THY-1+ > THY-1- 
-THY-1+, LNGFR+> THY-1+, LNGFR- > THY-1-, LNGFR+> 
THY-1-, LNGFR- 
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-BMSCs:0.030.03    -
SySCs:0.030.01 
LNGFR 
-BMSCs:0.030.04    -
SySCs:0.130.16 
THY-1 




-BMSCs:98.01.36    -
SySCs:97.80.12 
CD44: 
-BMSCs: 97.70.92   -
SySCs:95.13.72 
CD105: 
-BMSCs: 94.63.19   -
SySCs:97.20.45 
CD166: 
-BMSCs: 96.91.78   -
SySCs:97.51.14 
 THY-1: 




-Runx2 and OCN to β- actin: SySCs < BMSCs (less than 3-fold) 
Alizarin red staining(14 d) 
-SySCs < BMSCs 
-Chondrogenic capacity assessed by Toluidine blue and 
Safranin O staining: SySCs > BMSCs 
Gao X et al., (2015) -Human SMSC from skeletal 
muscle biopsies  
 
-Human BMSCs from bone 























-SMSCs: at P 8  
-BMSCs: at P 2 
 Differentiation(after 4 w) 
MicroCT (mineralized pellet volumes(mm2)):(3, 4 w) 
- Non-transduced BMSCs< transduced BMSCs 
- Non-transduced SMSCs < transduced SMSCs 
ALP activity 
-ALP + rates were different in cells obtained from various 
donors 
-A very small % of SMSCs and BMSCs showed ALP activity 
-BMP2 transduction affected the ALP activity 
positively/negatively 
RT-PCR 
BMPR2: SMSCs	≅ BMSCs      
BMPR1b: SMSCs< BMSCs       
SOX-9: BMSCs> SMSCs          
COX-2: transduced cells showed higher COX-2 expression 
-Lenti-viral BMP2 transduction had no + effect on SOX 9, 
BMPR2, BMPR1b expression 
-The BMSCs could be cultured up to P 10 and the SMSCs up to 
P 20 without any considerable phenotype change.  
Von Kossa staining: 
-BMSCs:  
Untransduced: mineralization mainly at the periphery of the 
pellets. 
Transduced: mineralization in both periphery & center of the 
pellets  
-SMSCs : 
Untransduced: mineralization throughout the entire pellet 
Transduced: increased extent of mineralization 
OCN IHC: 
BMSCs and SMSCs expressed OCN in the same location of Von 
Kossa stained parts.   
Rui, YF et al.,(2012) -TSCs isolated from the 
midsubstance of rat patellar 
tendons  
 
-BMSCs  isolated from rat 










ALP activity(3 d): 
-Without and with BMP-2: TSCs> BMSCs 
-BMP-2 enhanced ALP activity in TSCs but not in BMSCs. 
Alizarin red staining(10 d): 
-Without and with BMP-2: TSCs> BMSCs 
-BMP-2 enhanced calcium formation significantly in TSCs and 
less in BMSCs. 
RT-PCR: 
BMPR-IA, BMPR-II: TSCs> BMSCs 
BMPR-IB: TSCs> BMSCs with no significant difference 
Western blot analysis: 
-BMPR-IA, BMPR-IB, BMPRII: TSCs> BMSCs 
Van Gastel N et al., 
(2012) 
-PDCs of diaphyseal bone 






Flow cytometry(P 1) 
-PDC: 
CD105:50.6 ± 1.5            
CD90:50.5± 8.1 
Proliferation/viability: 
Cell count and Growth curves(0-14 d)  
-PDC > BMSC > TOB 
Population doubling time(h): 
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-TOBs of murine  
 
-BMSCs 




CD11b:3.0±0.7                
CD45:3.2±1.2 




-PDC cells expressing 
hematopoietic or 
endothelial markers 
reduced to <1% by P 3. 
 
-Regarding the Sca-1+ 
CD45- cells, peroisteum 
showed higher amount of 
MSCs compared to the 
bone marrow stroma. 
-TOB > BMSC ≅ PDC  
CFU assay: 
-Sca-1+CD45- fraction of the periosteum showed higher 
colonies than Sca-1-CD45-. 
Differentiation(14, 21 d) 
ALP activity(14 d): 
-ALP activity of PDC was upregulated from day 0 to day 14. 
Alizarin red  staining(21 d) 
-Mineralized nodules were observed in PDC. 
 RT-PCR(0, 21 d) 
-Runx 2, osterix, Col1a1, OCN: TOB > PDC 
-Osterix, OPN, OCN:PDC d 21> PDC d 0 













 Differentiation(21 d): 
Calcium content(Quantitative analysis of mineral formation): 
-f BM>f blood>f liver> BMSC 
RT-PCR: 
-OCN, BMP2: f BM>f liver>f blood> BMSC 
-ON, PCE, IGFII, Col1: f blood> f liver> f BM> BMSC 
-BSP, OPN, Met2A, OPG, PHOS1, SORT, ALP, CBFA1, OSX, 
NOG:  
f BM>f blood >f liver > BMSC 
Von Kossa staining: 
Highest: f BM 
Liu W et al., (2013) -PDLSCs from the  middle 







Cells were also 











CD90:                               CD105: 
-PDLSCs:99.9                  -
PDLSCs:99.3 
-BMSCs:98.6                   -
BMSCs:99.8 
CD146:                             STRO-
1: 
-PDLSCs:86.6                  -
PDLSCs:24.2 
-BMSCs:78.1                   -
BMSCs:36.6 
CD14:                              CD31: 
-PDLSCs:5.4                   -
PDLSCs:3.4 






-PDLSCs and BMSCs showed similar niches of cells and 
colonies. 
MTT assay, EDU assay , DNA content(7 d): 
-No significant difference observed in terms of proliferation 
assays 
Differentiation: 
Analysis without TNF-α under osteogenic induction 
ALP activity(7 d), Alizarin Red staining, calcium content (14 d): 
-BMSCs> PDLSCs 
RT-PCR(7 d): 
-ALP, RUNX2: BMSCs> PDLSCs 
Analysis in OM with/without TNF-α  
ALP activity(7 d):  
-BMSCs> PDLSCs> BMSCs+ TNF-α> PDLSCs+ TNF-α 
Alizarin red staining, calcium content(14 d): 
-BMSCs> BMSCs+ TNF-α> PDLSCs> PDLSCs+ TNF-α 
RT-PCR(7 d): 
ALP, RUNX2: BMSCs>BMSCs+ TNF-α>PDLSCs> PDLSCs+ 
TNF-α 


























CD90:                          CD29: 
BMSCs: 97.6               BMSCs: 
90.9 
Mb-MSCs: 87.6           Mb-
MSCs: 99.8 
Pl-MSCs: 91.1             Pl-
MSCs: 99.8 
CD105:                        CD73: 
BMSCs: 99.7               BMSCs: 
98.7 
Mb-MSCs: 96.7           Mb-
MSCs: 99.8 
Pl-MSCs: 99.2             Pl-
MSCs: 99.5 
-The number of MSCs 
isolated from the 
membrane was higher than 
placenta. (15.67% vs. 
2.14%) 
Proliferation/viability: 
Cell count(24, 48, 72 h): 
-Mb-MSCs ≅ Pl-MSCs > BMSCs at same Ps of 5, 10, 15. 
-Mb-MSCs and Pl-MSCs cultured to P 15 without morphology 
changes or proliferation reduction. While, BMSC discontinued 
proliferating after Ps 7 to 8. 
Differentiation: 
Alizarin red staining without osteoactivin(21 d): 
-Mb-MSCs ≅ BMSCs 
Alizarin red staining with osteoactivin(7, 14, 21 d) data is 
presented for d 21: 
-Addition of osteoactivin increased the osteogenic 
differentiation of Mb-MSCs and BMSCs. 
-Mb-MSCs > BMSCs 
215                                                                                                                                                                                                         Shahriyari et al. 
 
Regeneration, Reconstruction & Restoration 2017;2(2):202-219 
Amini AR et al., 
(2012) 











BMSCs  from 






















- PB-EPC: spindle-shape cells that formed cobblestone colonies 
after 2-3 weeks the same as human umbilical vein endothelial 
cells 
- BM-EPC: spindle-shape cells formed colonies with these cells 
Differentiation: 
RT-PCR(4 d): 
BMP-2:MSCs> PB-EPCs> BM-EPCs 
Col I: MSCs≅ PB-EPCs> BM-EPCs 
BMP-4: PB-EPCs>MSCs> BM-EPCs 
BMP-2, Col I,BMP-4: PB-EPC+MSC> BM-EPC+MSC 
-BMP-2 and BMP-4 expression of both cells increased as the 
fraction of the co-cultured MSCs increased. This behavior was 
not observed for Col I expression. 
ALP activity(14 d): 
-MSCs> PB-EPCs > BM-EPCs 
-PB-EPC+MSC>BM-EPC+MSC  
-Increasing MSC fraction of the co-culture enhanced ALP 
activity in  
PB-EPC, but did not affect BM-EPC 
Lee SY et al., (2007) -Human HCs from patients 
suffering isolated anterior 












Flow cytometry(P 0): 
CD29 
-HCs: 80.121.8       -
BMSCs: 89.511.7 
CD44 
-HCs:86.911.4        -
BMSCs: 86.911.9 
CD105 
-HCs:68.732.3         -
BMSCs:85.412.5 
CD166 
-HCs:20.75.2           -
BMSCs:62.018.3 
CD14 
-HCs: 0.90.6            -
BMSCs: 0.80.5 
CD34 
-HCs: 3.72.9            -
BMSCs: 0.50.2 
CD45 
-HCs: 0.9	0.4           -
BMSCs:1.8	0.1 
Proliferation/viability: 




Phase contrast microscope: 
-HCs displayed a fibroblast-like spindle shape morphology and 
form visible colonies around day 5.after 3-4 weeks cells formed 
a monolayer of fibroblastoid cells. 
-BMSCs colonies were similar to colony-forming unit-
fibroblasts of HCs. 
Differentiation: 
Alizarin red staining(21 d): 
-Both cells formed mineralized matrix in OM while there was 
no evidence of mineralized matrix in original medium. 
RT-PCR(3 w): 
-Both cells showed osteogenic potential by expressions of ALP, 
OCN, OPN, and BSP in OM. 
Yang H et al.,(2013) -Human GMSCs from 
gingival tissues surrounding 
the tooth sockets of extracted 
third molars 
-Human PDLSCs from 
periodontal ligament of 


























GMSCs= 97                  
PDLSCs= 96.5 
CD 146: 
GMSCs= 55.2               
PDLSCs= 44.2 
CD STRO 1: 




CFU assay (14 d) 
-GMSCs >PDLSCs 
MTT assay: (3 d) 
-d 1,2: GMSCs ≅PDLSCs 
-d 3: GMSCs > PDLSCs  
Differentiation (P4) 
ALP activity With or without TNF- α and interleukin IL-1b 
-PDLSCs > GMSCs 
Alizarin red staining (4 w) 
-PDLSCs > GMSCs 
RT-PCR (10 d) With or without TNF- α and interleukin IL-1b 
OCN: 
PDLSCs > GMSCs 
Runx2: 
PDLSCs > GMSCs 
Col 1: 
PDLSCs > GMSCs 





were treated with 
- Proliferation/viability: 
MTS assay(5 d): 
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-SHED from pulp of human 






with RA or Dex by 
given 
concentrations: 
-1, 10 and 100 nM 
Dex  
-0.5, 1, and 2 μM 
RA 
-PDLSCs and SHEDs: control>1 nM Dex>0.5, 1, 2 μM RA> 10 nM 
Dex>100 nM Dex 
-In contrast to RA treatment, Dex inhibited cell proliferation in 
a dose-dependent manner. 
- PDLSCs> SHEDs under RA &. PDLSCs≅ SHEDs by Dex 
treatment 
Differentiation: 
ALP activity(7, 14 d): 
- PDLSCs and SHEDs: 2 μM RA> 1 μM RA >0.5 μM RA>1, 10, 
100 nM Dex> control  
- PDLSCs< SHEDs under RA &. PDLSCs≅ SHEDs by Dex 
treatment 
Alizarin red staining and Von kossa staining (3, 4 w): 
-PDLSCs and SHEDs: RA treated groups>control and detected 
after 3 weeks while Dex groups deposition recognized after 4 
weeks. 
-PDLSCs> SHEDs after RA treatment 
RT-PCR(7 d): 
- SHED :RA treatment: Dex treatment: 
ALP, Runx2, OPN upregulated Runx2 upregulated 
 ON:not affected ALP,OPN,ON not affected  
 Col I downregulated Col I downrwgulated 
-PDLSC: RA treatment: Dex treatment: 
ALP upregulated ALP,Runx2, OPN not affected 
 Runx2, OPN,ON not affected ON not affected 
  ColI downregulated ColI downrwgulated 
-ALP expression: PDLSCs< SHEDs under RA&. PDLSCs≅ 
SHEDs by Dex treatment 
Western blot analysis(7 d): 
PDLSCs and SHEDs: Runx2, OPN production was promoted 
by RA and Dex treatments. 
Yu s et al.,(2012) -PDLSCs derived from 
periodontal ligament in the 
middle one third of the roots 
of extracted human third 
molars 
 
















Cell number(3, 5, 7 d): 
-WJSCs> PDLSCs 
Cell growth curve: 
- WJSCs proliferated faster than PDLSCs. 
Population doubling time(h): 
- WJSCs: 22.23  
- PDLSCs: 27.51 
Differentiation: 
ALP activity(0, 3, 5, 7 d) and Alizarin red staining(2, 3 w): 
- PDLSCs> WJSCs in control and OM 
Calcium content(ng)(0, 2, 3 w): 
-OM: PDLSCs> WJSCs 
-Control medium: PDLSCs ≅ WJSCs ≅ 0 
RT-PCR(0, 1, 2, 3 w): 
Osterix, BSP: PDLSCs> WJSCs 
OPN: WJSCs> PDLSCs 
OCN, Runx2: PDLSCs ≅ WJSCs 
-Expression level of RNAs in control medium was lower and 
approximately consistent to data in OM. 
Okumachi E et 
al.,(2014) 
-Rat TA- MSCs (TA; fast 
muscle) 
 










TA- MSCs= 94.1±3.0  
SO- MSCs= 93.5±1.1  
 
CD90: 
TA- MSCs= 98.5±0.3  
SO- MSCs= 95.5±0.6  
 
CD 29: 
TA- MSCs = 97.0±0.5  
SO- MSCs = 87.8±4.8 
 
CD34: 
TA- MSCs= 0.2±0.0  
SO- MSCs= 0.3±0.2  
 
CD45: 
TA- MSCs= 0.1±0.1  
SO- MSCs= 0.1±0.0  
 
Proliferation/viability (P 11) 
CFU assay (Colony number per 104 cells) 
-TA- MSCs : 48.1±9.8  
-SO- MSCs :94.3±19  
CFU assay (Colony number per volume (mg)) 
- TA- MSCs :4.4±0.6  
- SO- MSCs :24.6±10.5 
Differentiation: 
Alizarin red Staining (28 d)  
-Mineralization observed in both cells with rich calcium 
deposits. 
RT-PCR(7, 14, 21 d) 
d 7: 
Runx2: TA- MSCs > SO- MSCs 
ALP: TA- MSCs > SO- MSCs 
OPN: TA- MSCs > SO- MSCs 
d14: 
Runx2: TA- MSCs > SO- MSCs 
ALP: TA- MSCs > SO- MSCs 
OPN: TA- MSCs > SO- MSCs 
d21: 
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CD 11b: 
TA- MSCs= 1.1±0.5  
SO- MSCs= 0.2±0.1  
 
Runx2: TA- MSCs > SO- MSCs 
ALP: TA- MSCs > SO- MSCs 
OPN: TA- MSCs = SO- MSCs 







OM or control 
medium 
- Differentiation(3 w): 
Von Kossa staining: 
-FPl-MSCs showed calcium deposition in OM. While, MPl-
MSCs cultured in OM and both in control medium did not. 
Calcium content(µg/µg DNA): 
-FPl-MSCs in OM ≅200 
-MPl-MSCs in OM and FPl-MSCs, MPl-MSCs in control 
medium ≅0 
RT-PCR: 
(OPN, OCN, ALP, and Col I in control medium) 
-FPl-MSCs and MPl-MSCs expressed the markers but the 
expression did not change after 3 weeks of culture. 
Abe S et al., (2012) -APDCs obtained from the 
tip of the root of developing 
teeth with 
immature apex 
-CPCs obtained from the 
coronal portion of teeth 
Cells were plated 
on super-
hydrophilic plates, 










Flow cytometry and 
DAPI: 
APDCs:  
CD105 and CD166:+ 
Spheres derived from 
APDCs: 
-Expression of CD105 
reduced and CD166 
expression was lost. 
Proliferation/viability: 




Phase contrast microscopic photographs: 
-Both cells showed similar fibroblastic morphology. 
Differentiation: 
Alizarin red staining: 
-Sphere-forming cells derived from APDCs differentiated into 
mineralizing cells. 
 
importance in osteogenesis. Peister followed differentiation 
capacity of AFSCs and BMSCs on PCL-collagen scaffolds for 
3, 5, 10, 15 weeks. He found that although BMSCs have 
prompt differentiation and earlier mineralized matrix 
formation, AFSCs showed greater mineralized matrix and 
calcium content after 15 weeks of culturing (53). The distinct 
time point of cell differentiation supports the efficacy of co-
culturing approaches. 
Conclusion 
This study showed that the origins of MSCs impel their 
proliferative and osteogenic sufficiency and thus influence 
their application as a cell sources for bone tissue engineering. 
Human BMSCs demonstrated superior osteogenicity and 
human DPSCs showed the best cell proliferation on the 
scaffold. Although BMSCs are the best cellular nominee for 
cell based bone regeneration and most papers support their 
osteogenic capacity in vitro, assessment of their ability in vivo 
is of greater clinical value. 
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